olivlawolivlaw

olivLaw · US equity research

RPM International Inc. RPM

Paints, Varnishes, Lacquers, Enamels & Allied Prods · SIC 2851 · Vertical: Chemicals and allied products (SIC 28xx)

109.05USD+3.51% · 1 dayClose 04 Nov 2026

RPM International makes and sells specialty coatings, paints, roofing systems, sealants and adhesives for construction, industrial and consumer markets, with net sales of 7.9 billion USD in fiscal 2026. The company is now in a period of organic growth in its PCG and Consumer segments while construction demand stays soft, and management raised its fiscal 2027 outlook for sales and adjusted EBITDA.

At the close of 04 Nov 2026, RPM International Inc. (RPM) stock was 109.05 USD (+3.51% on the day), with market capitalisation 13.9 bn USD, P/E 20.2 on diluted EPS of 5.41 USD over the last 12 months, dividend yield 1.31%, beta 0.91, 52-week range 93.23–120.17 USD. Latest reported quarter (Q1 2027): revenue of 2.2 bn USD (+4.8% YoY), net income of 256.4 m USD (+12.6% YoY), diluted EPS 2.01 USD.

Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.

Market cap
13.9 bn USD
shares as of 30 Sept 2026
P/E (TTM)
20.2
Diluted EPS TTM 5.41 · TTM to 31 Aug 2026
E/P (TTM)
4.96%
TTM to 31 Aug 2026
Dividend yield
1.31%
DPS 12m 1.43
Beta (2y)
0.91
Volatility (1y) 30%
52-week range
93.23120.17

Price history

Loading chart…

Technical reading

RSI (14)
67.2
strong (55–70)
Bollinger (20, 2)
94.29 – 107.05
above the upper band · %B 1.16 · band width 12.7%
SMA 50 / 200
100.79 / 105.24
mixed trend
MACD (12, 26, 9)
1.43 / 0.28
MACD above signal

Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).

Performance

CompanyS&P 500vs S&P 500Vertical median
1 month+14.4%−1.1%+15.5 pp—
3 months−6.6%−0.5%−6.1 pp—
6 months+6.5%+4.4%+2.1 pp—
Year to date+4.9%+12.3%−7.5 pp—
1 year+0.9%+13.5%−12.7 pp+28.5%
3 years+13.2%+76.4%−63.2 pp+48.6%
5 years+21.5%+63.7%−42.2 pp—
Max drawdown (1y)
−22.4%
12 Feb 2026 → 20 Mar 2026
Max drawdown (5y)
−33.5%
25 Nov 2024 → 20 Mar 2026
Compound annual growth (5y)
+4.0%
S&P 500 +10.4%

Price returns, dividends excluded.

Quarterly results

Latest quarter: Q1 2027 · 31 Aug 2026

Revenue
2.2 bn USD
+4.8% YoY
Net income
256.4 m USD
+12.6% YoY
Diluted EPS
2.01
+13.6% YoY
net / operating
11.6% / unavailable

Quarterly margins

Quarterly statements · USD

Fiscal yearQ2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27
Revenue1.8 bn1.5 bn2.1 bn2.1 bn1.9 bn1.6 bn2.2 bn2.2 bn
Cost of revenue1.1 bn909.1 m1.2 bn1.2 bn1.1 bn973.1 m1.3 bn1.3 bn
Gross profit764.5 m567.5 m881.8 m893.2 m780.2 m634.8 m950.0 m914.0 m
SG&A529.8 m501.7 m592.8 m573.5 m549.5 m533.9 m635.3 m559.8 m
Depreciation & amortisation46.6 m ≈47.3 m ≈53.7 m51.5 m52.0 m ≈52.3 m ≈57.7 m53.1 m
Interest expense23.2 m23.0 m25.9 m29.3 m28.0 m26.9 m27.3 m25.5 m
Pre-tax income213.0 m41.0 m248.4 m298.0 m211.0 m69.3 m292.0 m337.1 m
Income tax29.5 m-11.4 m22.4 m70.2 m49.5 m17.7 m70.4 m80.4 m
Net income183.2 m52.0 m225.8 m227.6 m161.2 m51.4 m221.2 m256.4 m
Diluted EPS1.420.401.77 ≈1.771.260.401.74 ≈2.01
Operating cash flow279.4 m ≈91.5 m ≈149.2 m237.5 m345.7 m ≈73.5 m ≈242.0 m263.9 m
Capex50.0 m ≈58.2 m ≈71.0 m62.5 m49.3 m ≈47.8 m ≈63.9 m58.5 m
Dividends paid65.6 m ≈65.6 m ≈65.5 m64.5 m69.2 m ≈69.1 m ≈68.9 m68.1 m
Share repurchases17.5 m ≈17.5 m ≈17.5 m17.5 m17.5 m ≈17.5 m ≈25.0 m22.4 m

≈ derived quarter (cumulative difference / share-days average)

E/P over time

E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.

Today's P/E sits at the 8 percentile of its own 40-quarter history (min 17.8, median 25.0, max 41.1; quarters with earnings only).

Fiscal years

Fiscal year20192020202120222023202420252026
Revenue5.6 bn5.5 bn6.1 bn6.7 bn7.3 bn7.3 bn7.4 bn7.9 bn
Revenue YoY+4.6%−1.0%+10.9%+9.8%+8.2%+1.1%+0.5%+6.7%
Net income266.6 m304.4 m502.6 m491.5 m478.7 m588.4 m688.7 m661.4 m
Net income YoY−21.1%+14.2%+65.1%−2.2%−2.6%+22.9%+17.0%−4.0%
Diluted EPS2.012.343.873.793.724.565.355.17
Diluted EPS YoY−19.6%+16.4%+65.4%−2.1%−1.8%+22.6%+17.3%−3.4%
net %4.8%5.5%8.2%7.3%6.6%8.0%9.3%8.4%
Free cash flow156.2 m402.2 m609.0 m-43.7 m322.7 m908.3 m538.3 m675.2 m

Reported results vs expectations

Loading…

Balance sheet & financial health

Fiscal year 2026 · 31 May 2026

Cash
315.2 m USD
Financial debt
407.8 m USD
Net debt
92.6 m USD
Equity
3.3 bn USD
Total assets
8.3 bn USD
Debt / equity
0.12x
Current ratio
1.68x
ROE
21.3%
ROA
8.2%
FCF margin
8.6%

Financial statements (source on every figure)

Revenue and net income (USD)

Margins

Income statement · USD

Revenue
2024
7.3 bn
2025
7.4 bn
2026
7.9 bn

SEC (XBRL)· 22 Jul 2026verified

Cost of revenue
2024
4.3 bn
2025
4.3 bn
2026
4.6 bn

SEC (XBRL)· 22 Jul 2026verified

Gross profit
2024
3.0 bn
2025
3.1 bn
2026
3.3 bn

SEC (XBRL)· 22 Jul 2026verified

Research & development
2024
92.2 m
2025
94.7 m
2026
97.9 m

SEC (XBRL)· 22 Jul 2026verified

SG&A
2024
2.1 bn
2025
2.2 bn
2026
2.3 bn

SEC (XBRL)· 22 Jul 2026verified

Depreciation & amortisation
2024
171.3 m
2025
193.8 m
2026
213.5 m

SEC (XBRL)· 22 Jul 2026verified

Interest expense
2024
118.0 m
2025
96.5 m
2026
111.5 m

SEC (XBRL)· 22 Jul 2026verified

Pre-tax income
2024
787.8 m
2025
792.8 m
2026
870.3 m

SEC (XBRL)· 22 Jul 2026verified

Income tax
2024
198.4 m
2025
102.4 m
2026
207.9 m

SEC (XBRL)· 22 Jul 2026verified

Net income
2024
588.4 m
2025
688.7 m
2026
661.4 m

SEC (XBRL)· 22 Jul 2026verified

Diluted EPS
2024
4.56
2025
5.35
2026
5.17

SEC (XBRL)· 22 Jul 2026verified

Weighted average diluted shares
2024
128.3 m
2025
128.2 m
2026
127.6 m

SEC (XBRL)· 22 Jul 2026verified

Balance sheet · USD

Cash
2024
237.4 m
2025
302.1 m
2026
315.2 m

SEC (XBRL)· 22 Jul 2026verified

Receivables
2024
1.4 bn
2025
1.5 bn
2026
1.7 bn

SEC (XBRL)· 22 Jul 2026verified

Inventories
2024
956.5 m
2025
1.0 bn
2026
1.1 bn

SEC (XBRL)· 22 Jul 2026verified

Current assets
2024
2.9 bn
2025
3.2 bn
2026
3.5 bn

SEC (XBRL)· 22 Jul 2026verified

Property, plant & equipment, net
2024
1.3 bn
2025
1.5 bn
2026
1.6 bn

SEC (XBRL)· 22 Jul 2026verified

Goodwill
2024
1.3 bn
2025
1.6 bn
2026
1.7 bn

SEC (XBRL)· 22 Jul 2026verified

Intangibles (excl. goodwill)
2024
513.0 m
2025
780.8 m
2026
824.6 m

SEC (XBRL)· 22 Jul 2026verified

Total assets
2024
6.6 bn
2025
7.8 bn
2026
8.3 bn

SEC (XBRL)· 22 Jul 2026verified

Accounts payable
2024
649.7 m
2025
755.9 m
2026
853.5 m

SEC (XBRL)· 22 Jul 2026verified

Short-term debt
2024
136.2 m
2025
7.7 m
2026
407.8 m

SEC (XBRL)· 22 Jul 2026verified

Current liabilities
2024
1.5 bn
2025
1.5 bn
2026
2.1 bn

SEC (XBRL)· 22 Jul 2026verified

Equity
2024
2.5 bn
2025
2.9 bn
2026
3.3 bn

SEC (XBRL)· 22 Jul 2026verified

Cash flow · USD

Operating cash flow
2024
1.1 bn
2025
768.2 m
2026
898.7 m

SEC (XBRL)· 22 Jul 2026verified

Capex
2024
214.0 m
2025
229.9 m
2026
223.5 m

SEC (XBRL)· 22 Jul 2026verified

Free cash flow
2024
908.3 m ≈
2025
538.3 m ≈
2026
675.2 m ≈

SEC (XBRL)· 22 Jul 2026derived

Investing cash flow
2024
-206.4 m
2025
-825.5 m
2026
-417.2 m

SEC (XBRL)· 22 Jul 2026verified

Financing cash flow
2024
-890.0 m
2025
121.9 m
2026
-482.2 m

SEC (XBRL)· 22 Jul 2026verified

Dividends paid
2024
231.9 m
2025
255.6 m
2026
271.7 m

SEC (XBRL)· 22 Jul 2026verified

Share repurchases
2024
55.0 m
2025
70.0 m
2026
77.5 m

SEC (XBRL)· 22 Jul 2026verified

Computed indicators

Growth

Revenue growth (YoY)
6.7%
computed by olivLawFY 2026
Revenue CAGR 3Y
2.7%
computed by olivLawFY 2023 → FY 2026
Revenue CAGR 5Y
5.2%
computed by olivLawFY 2021 → FY 2026
EBIT growth (YoY)
unavailable
input data missing
Net income growth (YoY)
-4.0%
computed by olivLawFY 2026
Net income CAGR 3Y
11.4%
computed by olivLawFY 2023 → FY 2026
Net income CAGR 5Y
5.6%
computed by olivLawFY 2021 → FY 2026
EPS growth (YoY)
-3.4%
computed by olivLawFY 2026
EPS CAGR 3Y
11.6%
computed by olivLawFY 2023 → FY 2026
EPS CAGR 5Y
6.0%
computed by olivLawFY 2021 → FY 2026
FCF growth (YoY)
25.4%
computed by olivLawFY 2026

Profitability

Gross margin
41.2%
computed by olivLawTTM to 31 Aug 2026
EBITDA margin
unavailable
input data missing
EBIT margin
unavailable
input data missing
Net margin
8.7%
computed by olivLawTTM to 31 Aug 2026
FCF margin
8.9%
computed by olivLawTTM to 31 Aug 2026

Returns

ROE
21.1%
computed by olivLawTTM to 31 Aug 2026 · balance sheet at 31 Aug 2026
ROA
8.5%
computed by olivLawTTM to 31 Aug 2026 · balance sheet at 31 Aug 2026
ROIC
unavailable
input data missing
ROCE
unavailable
input data missing
Payout ratio (EPS)
unavailable
input data missing
Payout ratio (FCF)
39.0%
computed by olivLawTTM to 31 Aug 2026

Balance sheet

Net debt
94.7 m USD
computed by olivLawbalance sheet at 31 Aug 2026
Net debt / EBITDA
unavailable
input data missing
Debt / equity
0.1x
computed by olivLawbalance sheet at 31 Aug 2026
Interest coverage
unavailable
input data missing

Liquidity

Current ratio
1.8x
computed by olivLawbalance sheet at 31 Aug 2026
Quick ratio
1.2x
computed by olivLawbalance sheet at 31 Aug 2026
Cash ratio
0.2x
computed by olivLawbalance sheet at 31 Aug 2026

Cash

Operating cash flow
925.1 m USD
computed by olivLawTTM to 31 Aug 2026
Capital expenditure
219.6 m USD
computed by olivLawTTM to 31 Aug 2026
Free cash flow
705.6 m USD
computed by olivLawTTM to 31 Aug 2026
FCF conversion
102.2%
computed by olivLawTTM to 31 Aug 2026
Cash conversion
unavailable
input data missing

Efficiency

Days sales outstanding
69 days
computed by olivLawTTM to 31 Aug 2026 · balance sheet at 31 Aug 2026
Days inventory outstanding
86 days
computed by olivLawTTM to 31 Aug 2026 · balance sheet at 31 Aug 2026
Days payables outstanding
64 days
computed by olivLawTTM to 31 Aug 2026 · balance sheet at 31 Aug 2026
Cash conversion cycle
90 days
computed by olivLawTTM to 31 Aug 2026 · balance sheet at 31 Aug 2026

Market and valuation

Market capitalisation
13.9 bn USD
computed by olivLawbalance sheet at 31 Aug 2026
Enterprise value
14.0 bn USD
computed by olivLawbalance sheet at 31 Aug 2026
Market cap / net income TTM
20.2x
computed by olivLawTTM to 31 Aug 2026
P/E (TTM)
20.2x
computed by olivLawTTM to 31 Aug 2026
Earnings yield
5.0%
computed by olivLawTTM to 31 Aug 2026
P/B
4.0x
computed by olivLawbalance sheet at 31 Aug 2026
P/S
1.7x
computed by olivLawTTM to 31 Aug 2026 · balance sheet at 31 Aug 2026
EV/EBITDA
unavailable
input data missing
EV/EBIT
unavailable
input data missing
EV/Sales
1.8x
computed by olivLawTTM to 31 Aug 2026 · balance sheet at 31 Aug 2026
P/FCF
19.7x
computed by olivLawTTM to 31 Aug 2026 · balance sheet at 31 Aug 2026
FCF yield
5.1%
computed by olivLawTTM to 31 Aug 2026 · balance sheet at 31 Aug 2026
Dividend yield
1.3%
computed by olivLawTTM to 31 Aug 2026
Shareholder yield (distributions)
2.6%
computed by olivLawTTM to 31 Aug 2026 · balance sheet at 31 Aug 2026

Risk

Altman Z
unavailable
input data missing

Valuation

olivLaw classification

Neutral profile

Score: 65 / 100

A scoring methodology on indicators and valuation, not investment advice.

Closing price

109.05 USD

04 Nov 2026Source: olivLaw, closing series

Market cap: 13.9 bn USD

Key indicators

Market capitalisation
13.9 bn USD
computed by olivLawbalance sheet at 31 Aug 2026
P/E (TTM)
20.2x
computed by olivLawTTM to 31 Aug 2026
P/B
4.0x
computed by olivLawbalance sheet at 31 Aug 2026
EV/EBITDA
unavailable
input data missing
ROE
21.1%
computed by olivLawTTM to 31 Aug 2026 · balance sheet at 31 Aug 2026
Net margin
8.7%
computed by olivLawTTM to 31 Aug 2026
Revenue growth (YoY)
6.7%
computed by olivLawFY 2026
Dividend yield
1.3%
computed by olivLawTTM to 31 Aug 2026

Coverage and freshness

31/37 reporting lines present
Latest full fiscal year: 2026
Latest reported period: 31 Aug 2026
Latest balance sheet date: 31 Aug 2026
Share count (cover of the latest filing), as of: 30 Sept 2026
Source: SEC (XBRL)published 06 Oct 2026
verified 2777derived 204

Score by group

  • Balance sheet80
  • Valuation73
  • Quality70
  • Growth50
  • Returns62

Estimated value range

Low
78.42
USD per share
Mid
94.68
USD per share
High
120.30
USD per share
Price: 109.05 USD
The price is within the range
Potential to the central value: -13.2% (value / price − 1)
Margin of safety: -15.2% (1 − price / value)
Agreement between methods: low · 3 methods used · 3 independent bases

The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 16.56 – 232.50 USD.

Valuation assumptions are editorial choices, not measured; beta is not measured.

Method ranges (USD per share)

— — Mid · ▏ Price

Valuation methods

  • DCF (discounted cash flow)78.42 – 120.30 (Mid 94.68)
    WACC 9.2% · starting FCFF 787.5 m USD · terminal value share of EV 73%
    The WACC × g sensitivity gives the method's bounds; these are not probabilities.
    Reverse DCF: starting growth implied by the price (fading linearly to terminal growth, everything else fixed): 9.0%
  • Peers: EV/EBITDAunavailable · input data missing
  • Peers: P/E111.23 – 232.50 (Mid 186.56)
    25 companies used · median multiple 34.5x · quartiles 20.6x – 43.0x
    ABBV, ABT, ALNY, AMGN, BMY, CF, CHD, CL, DD, ECL, EXEL, IDXX, JNJ, KVUE, LIN, LLY, LYB, PFE, PG, PPG, REGN, RPRX, UTHR, VRTX, ZTS
  • Dividend discount (DDM)16.56 – 22.27 (Mid 18.99)
Multiple comparisons use the SIC vertical: Chemicals and allied products (SIC 28xx)

Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.

Assumptions (illustrative, editorial)

Risk-free rate
4.3%
Equity risk premium
5.0%
Beta (default)
1.00
Cost of equity
9.3%
Terminal growth
2.5%

Factor scorecard

Neutral profile · Score 65/100

FactorValueScoreWeight used
ROIC · Qualityunavailableunavailable—
Net margin · Quality8.7%39 (vs peers)10%
FCF conversion · Quality102.2%100 (on a fixed band)10%
Revenue CAGR 3Y · Growth2.7%23 (on a fixed band)13%
EPS CAGR 3Y · Growth11.6%77 (on a fixed band)13%
Net debt / EBITDA · Balance sheetunavailableunavailable—
Interest coverage · Balance sheetunavailableunavailable—
Current ratio · Balance sheet1.8x80 (on a fixed band)7%
P/E (TTM) · Valuation20.2x80 (vs peers)17%
EV/EBITDA · Valuationunavailableunavailable—
FCF yield · Valuation5.1%63 (on a fixed band)13%
Shareholder yield (distributions) · Returns2.6%37 (on a fixed band)10%
Payout ratio (FCF) · Returns39.0%100 (on a fixed band)7%

Factors without a value were dropped; the remaining weights were renormalised.

Score groups

  • Balance sheet· partial80/100 · 1/3 factors with a value
  • Growth50/100 · 2/2 factors with a value
  • Quality70/100 · 2/3 factors with a value
  • Returns62/100 · 2/2 factors with a value
  • Valuation73/100 · 2/3 factors with a value

A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.

Memo

RPM International Inc. (RPM). Latest full fiscal year: 2026; data up to 2026-08-31.

Figures computed from the financial statements: revenue 7.9 bn USD in 2026; YoY growth 6.7%; net margin 8.7%; ROE 21.1%.

The estimated value range is 78.42–120.30 USD per share (median of 3 methods, agreement: low); assumptions are illustrative. Against the central value of 94.68 USD, the price of 109.05 USD leaves a potential of -13.2% (value / price − 1) and a margin of safety of -15.2% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.

olivLaw score 65/100, methodological classification: neutral profile (score, margin of safety and method agreement together; not a judgement of the right price). Groups assessed only in part: balance. Not investment advice.

Text generated deterministically from the figures shown; no language model. Not investment advice.

What supports the thesis

  • FCF conversion: 102.2%
  • EPS CAGR 3Y: 11.6%
  • Current ratio: 1.8x
  • P/E (TTM): 20.2x
  • Payout ratio (FCF): 39.0%

What contradicts it

  • Revenue CAGR 3Y: 2.7%
  • The valuation methods diverge

Not assessed (insufficient data or a ratio without meaning): ROIC, Net debt / EBITDA, Interest coverage, EV/EBITDA.

Versus the vertical median

Chemicals and allied products (SIC 28xx) · same major group (2-digit SIC) · compared with 39 companies

Multiples and returns vs the median

P/E
20.2x
vertical median 37.0x
below median (−45.5%)
EV/EBITDA
—
vertical median 20.2x
P/S
1.7x
vertical median 5.1x
below median (−65.7%)
P/B
4.0x
vertical median 6.1x
below median (−34.6%)
ROE
21.1%
vertical median 14.8%
above median (+42.7%)
Net margin
8.7%
vertical median 10.8%
below median (−19.7%)
EBIT margin
—
vertical median 17.1%
Revenue YoY
6.7%
vertical median 2.2%
above median (+196.0%)
Net debt/EBITDA
—
vertical median 0.1x
Dividend yield
1.3%
vertical median 2.1%
below median (−38.6%)

Price rebased to 100 (monthly, 5 years)

Companies in the vertical

Market capP/EROENet marginRevenue YoY1A / 3A
LLYEli Lilly And Company1,334.0 bn46.086.1%31.9%+44.7%+32% / +140%
JNJJohnson & Johnson665.2 bn41.920.0%16.2%+6.0%+34% / +79%
ONCBeone Medicines Ltd.558.4 bn869.914.7%10.7%+40.2%+11% / +102%
ABBVAbbVie Inc.521.1 bn50.7—15.7%+8.6%+29% / +107%
PGPROCTER & GAMBLE Co387.8 bn25.229.4%18.2%+3.3%+13% / +9%
MRKMerck & Co., Inc.370.7 bn154.75.1%3.6%+1.3%+43% / +47%
AMGNAmgen Inc.258.8 bn27.778.4%24.1%+10.0%+39% / +77%
LINLinde plc240.9 bn34.918.0%19.3%+3.0%+28% / +27%
GILDGilead Sciences, Inc.216.4 bn—-22.3%-12.5%+2.4%+39% / +128%
ABTAbbott Laboratories200.1 bn43.09.2%9.7%+5.7%−10% / +11%
PFEPfizer Inc175.5 bn43.94.4%6.3%−1.6%+20% / +1%
VRTXVertex Pharmaceuticals Inc139.2 bn35.320.8%30.7%+8.9%+27% / +55%
BMYBristol-Myers Squibb Company131.2 bn14.244.1%18.5%−0.2%+30% / +30%
MRNAModerna, Inc.103.2 bn—-39.0%-141.4%−39.9%+895% / +233%
ECLEcolab Inc.88.4 bn42.920.7%12.0%+2.2%+14% / +64%
CLColgate-Palmolive Company78.5 bn38.7358.9%9.6%+1.4%+23% / +25%
APDAir Products And Chemicals, Inc.71.0 bn—-0.3%-0.4%−0.5%+22% / +18%
IDXXIdexx Laboratories Inc55.0 bn47.168.9%25.4%+10.4%−7% / +50%
TEVATeva Pharmaceutical Industries Limited48.8 bn97.46.6%3.6%+4.3%+56% / +326%
RVMDRevolution Medicines, Inc.43.2 bn—-93.6%-946.8%unavailable+157% / +756%
BIIBBiogen Inc.37.6 bn108.81.9%3.4%+2.2%+40% / +9%
KVUEKenvue Inc.37.1 bn21.916.3%10.9%−2.1%+34% / +4%
ZTSZoetis Inc.36.9 bn14.764.4%27.5%+2.3%−30% / −50%
PPGPpg Industries Inc28.1 bn18.219.3%9.4%+0.2%+27% / −10%
ROIVRoivant Sciences Ltd.27.6 bn—-6.2%-3,535.0%−71.6%+84% / +300%

1- and 3-year price returns: for RPM from daily closes (the same as the performance table), for the other companies from month-end closes.

olivLaw engine forecast

The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.

The engine has no published run for this company yet.

Valuation scenarios (editable assumptions)

Illustrative scenarios

Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.

Bear
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Base
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Bull
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Nothing is saved.

Estimated price (USD)

Estimated priceBearBaseBull
1 years
63.31
Total return -42% · Per year -42%
112.03
Total return 3% · Per year 3%
168.88
Total return 55% · Per year 55%
3 years
59.26
Total return -46% · Per year -18%
118.19
Total return 8% · Per year 3%
195.94
Total return 80% · Per year 22%
5 years
55.47
Total return -49% · Per year -13%
124.70
Total return 14% · Per year 3%
227.34
Total return 108% · Per year 16%
What moves the 3-year price the most
  • Exit P/E± 29.55
  • Net margin± 20.68
  • Annual revenue growth± 17.27
  • Annual dilution± 1.74

AI analysis

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

In brief

RPM International makes and sells specialty coatings, paints, roofing systems, sealants and adhesives for construction, industrial and consumer markets, with net sales of 7.9 billion USD in fiscal 2026 1. The company is now in a period of organic growth in its PCG and Consumer segments while construction demand stays soft, and management raised its fiscal 2027 outlook for sales and adjusted EBITDA 3.

SWOT

Strengths

  • A broad portfolio of well-known brands and an extensive global presence with operations in dozens of countries 1.
  • Rising operating margins and solid operating cash flow, used for debt reduction and shareholder returns 23.
  • A diversified three-segment structure that reduces dependence on any single economic cycle 1.

Weaknesses

  • The CPG segment posted negative organic growth in the first quarter of fiscal 2027, showing exposure to commercial construction 3.
  • Total debt remains significant relative to equity, and a high debt load limits financial flexibility 1.
  • Warranty costs and customer credit risk can pressure results in some business lines 23.

Opportunities

  • Growing demand for high-performance building and infrastructure solutions in emerging markets, where the company reported growth above 20% 3.
  • Acquisitions that extend the portfolio, such as Volteco in waterproofing, could add growth in the CPG segment 3.
  • Consolidation of the fragmented paint and sealant market could open acquisition opportunities 1.

Threats

  • Raw material inflation, tariffs and supply chain disruptions could reduce margins if prices cannot be raised enough 12.
  • High interest rates and more cautious lending could reduce demand from construction and renovation 1.
  • Currency fluctuations affect sales and reported results in dollars, given the share of foreign operations 1.

Risks

  • Sensitivity to the construction cyclehigh

    Demand for the company's products depends on construction and renovation activity, which could decline if financing becomes more expensive 1.

  • Cost inflation and margin pressurehigh

    Rising raw material, labour and tariff costs could compress margins, and pricing may not fully offset them 12.

  • Indebtedness and access to capitalmedium

    A high debt level could limit flexibility and raise financing costs, especially if the credit rating were downgraded 1.

  • Goodwill and intangible asset impairmentmedium

    Significant goodwill and intangible assets could lead to impairment charges if reporting units fail to meet their carrying values 1.

  • Currency exposuremedium

    Exchange rates can affect sales, profit and the value of assets outside the United States, given the weight of international operations 1.

Investment thesis

What would need to be true (bull case)

  • If the PCG and Consumer segments sustain organic growth and MAP efficiencies continue, margins could gradually recover toward earlier levels.
  • Growth in emerging markets and strong brands could support long-term sales even in a difficult economic environment.
  • Rising operating cash flow could allow debt reduction and shareholder returns, which would strengthen the balance sheet.

What would break the thesis

  • If the CPG segment does not recover, overall results could remain below expectations, especially in healthcare and education.
  • If cost inflation persists and prices cannot be raised enough, margins could stay under pressure through the year.
  • Significant debt and the risk of goodwill impairment could limit options if the economic environment worsens.

What to watch

  • Return of organic growth in the CPG segmentQ2 fiscal 2027
  • Gross margin trend and the effect of pricing to offset inflationQ2 fiscal 2027
  • Investor day presentation on strategy and medium-term targetsNovember 2026
  • Annual results and any update to the fiscal 2027 outlooknext 10-K

Products, market & competition

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

The business

RPM International Inc., a Delaware corporation headquartered in Medina, Ohio, operates through subsidiaries that manufacture and sell specialty chemical product lines: high-performance paints, infrastructure repair products, protective coatings, roofing systems, sealants and adhesives 1. Brands include Tremco, Carboline, Rust-Oleum, DAP, Stonhard and Zinsser 1. Since June 2025 the company reports three segments instead of four after an internal realignment 1.

The company sells products in about 167 countries and territories and operates roughly 120 manufacturing locations, many outside the United States 1. About 31% of sales come from international markets, and in total foreign operations represent 29.8% of net sales 1. Customers include contractors, distributors, industrial manufacturers, public institutions and do-it-yourself consumers 1.

The model combines strong brands with a services network, for example roofing and building maintenance work performed by the Weatherproofing Technologies subsidiary 1. In the first quarter of fiscal 2027 the company also announced the acquisition of Volteco, an Italian supplier of below-grade waterproofing solutions, for its CPG segment 3.

Segments

Performance Coatings Group (PCG)

PCG covers about 27% of sales and includes industrial flooring, corrosion-control and fireproofing coatings, and food-industry coatings 1. It has been the fastest-growing segment recently, with record sales and strong organic growth in the first quarter of fiscal 2027, particularly in emerging markets 3.

Market context

The company describes the paints, coatings, adhesives and sealants market as fragmented and consolidating, with relatively high barriers to entry because of long development cycles and the importance of brand identity 1. Demand depends on construction activity, residential renovation and industrial cycles, and companies like RPM could benefit from sector consolidation if they keep a broad product range 1.

Cost pressure is significant: raw material inflation and tariffs cut the gross profit margin to 41.3% in the first quarter of fiscal 2027, down from 42.3% a year earlier 2. Management expects inflationary headwinds to be reflected in results throughout fiscal 2027 2.

Trends

  • Slow recovery in commercial constructionheadwind

    Commercial and residential construction activity remains weak, and high interest rates could make lenders more cautious; if demand does not recover, the CPG segment could stay under pressure 13.

  • Expansion of the Platform model in emerging marketstailwind

    Strong growth in emerging markets, driven by high-performance building and infrastructure solutions, suggests the Platform model could accelerate regional growth 3.

  • Cost inflation and tariffsheadwind

    Raw material inflation, supply shortages and tariffs are compressing margins, although price increases partly offset these pressures 23.

  • The MAP efficiency programmemixed

    The MAP 2025 initiatives for SG&A, manufacturing and procurement supported record adjusted EBITDA, and could keep supporting margins if sustained 23.

Competitive position

The company says its markets are fragmented and that no single competitor faces it across all products 1. Many competitors have greater financial resources and larger sales forces than RPM, though the company does not believe it holds a significant share of the worldwide protective coatings market 1.

Competition comes from local, regional, national and multinational firms, with different weight in each product line 1. In consumer products RPM faces players that hold large shelf space at home improvement retailers, and in construction it faces specialised sealant and roofing companies 1.

  • Sherwin-WilliamsSHW

    US paint and coatings maker active in both construction and industrial markets, representative of competition in the coatings segment.

  • PPG IndustriesPPG

    Maker of industrial and transportation coatings with strength in corrosion protection, a product line where RPM is also active.

  • H.B. FullerFUL

    Adhesives and sealants company for construction and industry, a direct competitor on RPM's sealant and adhesive lines.

  • MascoMAS

    Group that owns the Behr paint brand and home products, competing in the consumer and renovation segment.

News & filings

In the press

No news in our archive over the last 180 days.

SEC filings

Sources

  1. [1] Form 10-K, fiscal year ended 2026-05-31 · SEC / RPM International Inc. · 22 Jul 2026
  2. [2] Form 10-Q, quarter ended 2026-08-31 · SEC / RPM International Inc. · 06 Oct 2026
  3. [3] Form 8-K, results release (exhibit 99.1) · SEC / RPM International Inc. · 06 Oct 2026

Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.